Kai-Tan Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kai-Tan Cheng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chi-Hsin Chang
Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan
1 shared publication - Fan-Wei Lin
Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan
1 shared publication - Sheng-Chi Hung
Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan
1 shared publication Thomas Efferth
Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany
1 shared publication- Yet-Ran Chen
Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan
1 shared publication - Ying-Lan Chen
Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology National Cheng Kung University Tainan Taiwan
1 shared publication
Latest Publications
- Open Access
- 4 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
XCP1 cleaves Pathogenesis-related protein 1 into CAPE9 for systemic immunity in Arabidopsis
Proteolytic activation of cytokines regulates immunity in diverse organisms. In animals, cysteine-dependent aspartate-specific proteases (caspases) play central roles in cytokine maturation. Although the proteolytic production of peptide cytokines is also essential for plant immunity, evidence for cysteine-dependent aspartate-specific proteases in regulating plant immunity is still limited. In this study, we found that the C-terminal proteolytic processing of a caspase-like substrate motif “CNYD” within Pathogenesis-related protein 1 (PR1) generates an immunomodulatory cytokine (CAPE9) in Arabidopsis. Salicylic acid enhances CNYD-targeted protease activity and the proteolytic release of CAPE9 from PR1 in Arabidopsis. This process involves a protease exhibiting caspase-like enzyme activity, identified as Xylem cysteine peptidase 1 (XCP1). XCP1 exhibits a calcium-modulated pH-activity profile and a comparable activity to human caspases. XCP1 is required to induce systemic immunity triggered by pathogen-associated molecular patterns. This work reveals XCP1 as a key protease for plant immunity, which produces the cytokine CAPE9 from the canonical salicylic acid signaling marker PR1 to activate systemic immunity.
- 4 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessXCP1 cleaves Pathogenesis-related protein 1 into CAPE9 for systemic immunity in Arabidopsis
Proteolytic activation of cytokines regulates immunity in diverse organisms. In animals, cysteine-dependent aspartate-specific proteases (caspases) play central roles in cytokine maturation. Although the proteolytic production of peptide cytokines is also essential for plant immunity, evidence for cysteine-dependent aspartate-specific proteases in regulating plant immunity is still limited. In this study, we found that the C-terminal proteolytic processing of a caspase-like substrate motif “CNYD” within Pathogenesis-related protein 1 (PR1) generates an immunomodulatory cytokine (CAPE9) in Arabidopsis. Salicylic acid enhances CNYD-targeted protease activity and the proteolytic release of CAPE9 from PR1 in Arabidopsis. This process involves a protease exhibiting caspase-like enzyme activity, identified as Xylem cysteine peptidase 1 (XCP1). XCP1 exhibits a calcium-modulated pH-activity profile and a comparable activity to human caspases. XCP1 is required to induce systemic immunity triggered by pathogen-associated molecular patterns. This work reveals XCP1 as a key protease for plant immunity, which produces the cytokine CAPE9 from the canonical salicylic acid signaling marker PR1 to activate systemic immunity.